Sign in

CIK 0001157601

  • Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 267-824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
Open-market buys, last 90 days
$35,023,032
in 1 filing
Open-market sales, last 90 days
$6,669,998
in 2 filings, $6.7M under 10b5-1 plans

Net +$28,353,034. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-03-13 CRAVES FRED B Director Option exercise +7,742 $65.06 $504K 357,818
2025-03-13 CRAVES FRED B Director Sale −1,951 $322.45 $629K 355,867
2025-03-13 CRAVES FRED B Director Sale −1,649 $323.47 $533K 354,218
2025-03-13 CRAVES FRED B Director Sale −900 $324.69 $292K 353,318
2025-03-13 CRAVES FRED B Director Sale −800 $325.63 $261K 352,518
2025-03-13 CRAVES FRED B Director Sale −1,000 $327.63 $328K 351,518
2025-03-13 CRAVES FRED B Director Sale −400 $328.68 $131K 351,118
2025-03-13 CRAVES FRED B Director Sale −967 $329.86 $319K 350,151
2025-03-13 CRAVES FRED B Director Sale −75 $330.23 $25K 350,076
2025-03-13 CRAVES FRED B Director Option exercise · Stock Option (Right to Buy) −7,742 0
2025-03-12 CRAVES FRED B Director Option exercise +1,728 $65.06 $112K 351,804
2025-03-12 CRAVES FRED B Director Option exercise +6,000 $111.06 $666K 357,804
2025-03-12 CRAVES FRED B Director Sale −1,587 $330.54 $525K 356,217
2025-03-12 CRAVES FRED B Director Sale −2,759 $331.36 $914K 353,458
2025-03-12 CRAVES FRED B Director Sale −2,382 $332.38 $792K 351,076
2025-03-12 CRAVES FRED B Director Sale −800 $333.66 $267K 350,276
2025-03-12 CRAVES FRED B Director Sale −200 $334.97 $67K 350,076
2025-03-12 CRAVES FRED B Director Option exercise · Stock Option (Right to Buy) −1,728 7,742
2025-03-12 CRAVES FRED B Director Option exercise · Stock Option (Right to Buy) −6,000 0
2024-12-03 CRAVES FRED B Director Sale −3,080 $315.21 $971K 11,520

Page 1 of 4 · 77 trades